Improvement in health-related quality of life, independent of fasting glucose concentration, via insulin pen device in diabetic patients

Journal of Evaluation in Clinical Practice

Volumn 15, Issue 4, 2009, Pages 699-703

  Lee, I Te ^a,b   Liu, Hsiu Chen ^a   Liau, Yi Ju ^c   Lee, Wen Jane ^a   Huang, Chien Ning ^b   Sheu, Wayne Huey Herng ^a,b,d  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c JEN AI HOSPITAL   (Taiwan)

^d NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Insulin pen; QOL; SF 36; Syringe

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; FUNCTIONAL HEALTH PATTERNS; GENERAL CONDITION IMPROVEMENT; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; GLYCEMIC CONTROL; HEALTH STATUS; HUMAN; INSULIN PEN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MEDICAL INSTRUMENTATION; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT FORM 36; SYRINGE; TREATMENT DURATION;

DIABETES MELLITUS; DRUG DELIVERY SYSTEMS; FEMALE; GLUCOSE; GLYCEMIC INDEX; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; TAIWAN;

EID: 68349106964     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/j.1365-2753.2008.01086.x     Document Type: Article

References (19)

1. The Diabetes Control and Complications Trial (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. New England Journal of Medicine, 329, 977 986.
2. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 352, 837 853.
3. Ohkubo, Y., Kishikawa, H., Araki, E., Miyata, T., Isami, S., Motoyoshi, S., Kojima, Y., Furuyoshi, N. Shichiri, M. (1995) Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Research and Clinical Practice, 28, 103 117.
4. Bashoff, E. C. Beaser, R. S. (1995) Insulin therapy and the reluctant patient. Overcoming obstacles to success. Postgraduate Medical Journal, 97 (86-90 93 96.
5. Hunt, L. M., Valenzuela, M. A. Pugh, J. A. (1997) NIDDM patients' fears and hopes about insulin therapy. The basis of patient reluctance. Diabetes Care, 20, 292 298.
6. Chen, H. S., Hwu, C. M., Kwok, C. F., Yang, H. J., Shih, K. C., Lin, B. J. Ho, L. T. (1999) Clinical response and patient acceptance of a prefilled, disposable insulin pen injector for insulin-treated diabetes. Zhonghua Yi Xue Za Zhi (Taipei), 62, 455 460.
7. de Luis, D. A., Aller, R., Cuellar, L., Terroba, M. C., Ovalle, H. F., Izaola, O. Romero, E. (2004) Effect on quality of life with a new insulin injection device in elderly patients with diabetes mellitus type 2. Journal of Diabetes and Its Complications, 18, 216 219.
8. Graff, M. R. McClanahan, M. A. (1998) Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe. Clinical Therapeutics, 20, 486 496.
9. Kadiri, A., Chraibi, A., Marouan, F., et al. (1998) Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents. Diabetes Research and Clinical Practice, 41, 15 23.
10. Plevin, S. Sadur, C. (1993) Use of a prefilled insulin syringe (Novolin Prefilled) by patients with diabetes. Clinical Therapeutics, 15, 423 431.
11. Su, C. C., Chen, H. S. Lin, H. D. (2003) Glycemic control with different premixed insulin in Taiwanese people with type two diabetes mellitus. Journal of the Chinese Medical Association, 66, 155 159.
12. Gnanalingham, M. G., Newland, P. Smith, C. P. (1998) Accuracy and reproducibility of low dose insulin administration using pen-injectors and syringes. Archives of Disease in Childhood, 79, 59 62.
13. Hanestad, B. R. Albrektsen, G. (1991) Quality of life, perceived difficulties in adherence to a diabetes regimen, and blood glucose control. Diabetic Medicine, 8, 759 764.
14. Jacobson, A. M., Adler, A. G., Wolfsdorf, J. I., Anderson, B. Derby, L. (1990) Psychological characteristics of adults with IDDM. Comparison of patients in poor and good glycemic control. Diabetes Care, 13, 375 381.
15. Wikby, A., Stenstrom, U., Andersson, P. O. Hornquist, J. (1998) Metabolic control, quality of life, and negative life events: a longitudinal study of well-controlled and poorly regulated patients with type 1 diabetes after changeover to insulin pen treatment. Diabetes Educator, 24, 61 66.
16. Tseng, H. M., Lu, J. R. Tsai, Y. J. (2003) Assessment of health-related quality of life (II). Norming and validation of SF-36, Taiwan version. Taiwan Journal of Public Health, 22, 512 518 In Chinese).
17. Ware, J. E. Jr. Sherbourne, C. D. (1992) The MOS 36-Item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30, 473 483.
18. Lundman, B. Norberg, A. (1993) The significance of a sense of coherence for subjective health in persons with insulin-dependent diabetes. Journal of Advanced Nursing, 18, 381 386.
19. Chantelau, E., Schiffers, T., Schutze, J. Hansen, B. (1997) Effect of patient-selected intensive insulin therapy on quality of life. Patient Education and Counseling, 30, 167 173.